Biocryst Pharmaceuticals Inc
BCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882796
No open-market purchases or sales by Biocryst Pharmaceuticals Inc insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.61B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Biocryst Pharmaceuticals Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 234
- +16 vs. Q2 2022
- Shares held
- 148.6M
- −3.25M (−2.1%) vs. Q2 2022
- Total value
- $1.87B
- +$265.9M (+16.6%) vs. Q2 2022
- New holders
- 42
- 76 more added
- Sold out
- 26
- 59 more reduced
3 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 319 | $2.61B |
| Q1 2026 | 303 | $2.37B |
| Q4 2025 | 273 | $1.66B |
| Q3 2025 | 286 | $1.47B |
| Q2 2025 | 294 | $1.77B |
| Q1 2025 | 274 | $1.32B |
| Q4 2024 | 258 | $1.26B |
| Q3 2024 | 257 | $1.32B |
| Q2 2024 | 242 | $1.08B |
| Q1 2024 | 238 | $915.0M |
| Q4 2023 | 236 | $1.06B |
| Q3 2023 | 233 | $1.24B |
| Q2 2023 | 236 | $1.23B |
| Q1 2023 | 242 | $1.42B |
| Q4 2022 | 230 | $1.80B |
| Q3 2022 | 234 | $1.87B |
| Q2 2022 | 221 | $1.61B |
| Q1 2022 | 233 | $2.07B |
| Q4 2021 | 206 | $1.63B |
| Q3 2021 | 197 | $1.48B |
| Q2 2021 | 195 | $1.65B |
| Q1 2021 | 191 | $1.06B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Biocryst Pharmaceuticals Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Investments, LP | 1,031,159 | $13.0M | 0.04% | +788,618+325.1% | Added |
| Norges Bank | 1,073,116 | $13.5M | 0.00% | −912,249−45.9% | Reduced |
| Tang Capital Management LLC | 1,200,000 | $15.1M | 1.85% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 1,223,721 | $15.4M | 0.06% | +29,210+2.4% | Added |
| Millennium Management LLC | 1,326,442 | $16.7M | 0.02% | −622,153−31.9% | Reduced |
| Charles Schwab Investment Management Inc | 1,386,148 | $17.5M | 0.01% | +29,145+2.1% | Added |
| Sarissa Capital Management LP | 1,390,790 | $17.5M | 1.98% | 00.0% | Unchanged |
| GW&K Investment Management, LLC | 1,417,140 | $17.9M | 0.20% | +1,417,140 | New |
| Alkeon Capital Management LLC | 1,465,285 | $18.5M | 0.13% | +296,940+25.4% | Added |
| Goldman Sachs Group Inc | 1,469,155 | $18.5M | 0.01% | +92,443+6.7% | Added |
| Segall Bryant & Hamill, LLC | 1,681,189 | $21.2M | 0.25% | −142,020−7.8% | Reduced |
| Rock Springs Capital Management LP | 1,712,507 | $21.6M | 0.56% | +251,416+17.2% | Added |
| Northern Trust Corp | 1,796,791 | $22.6M | 0.01% | −20,093−1.1% | Reduced |
| First Manhattan Co | 1,805,072 | $22.7M | 0.10% | 00.0% | Unchanged |
| Stifel Financial Corp | 1,846,174 | $23.3M | 0.04% | −3,850−0.2% | Reduced |
| Nuveen Asset Management, LLC | 1,902,821 | $24.0M | 0.01% | −23,013−1.2% | Reduced |
| Two Sigma Advisers, LP | 2,015,812 | $25.4M | 0.07% | −67,600−3.2% | Reduced |
| PFM Health Sciences, LP | 2,162,411 | $27.2M | 1.04% | 00.0% | Unchanged |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2,280,953 | $28.7M | 0.11% | +181,626+8.7% | Added |
| Fairmount Funds Management LLC | 2,543,107 | $32.0M | 5.91% | −800,000−23.9% | Reduced |
| Assenagon Asset Management S.A. | 2,616,157 | $33.0M | 0.14% | −561,714−17.7% | Reduced |
| Artisan Partners Limited Partnership | 2,649,616 | $33.4M | 0.06% | −267,593−9.2% | Reduced |
| Geode Capital Management, LLC | 3,365,844 | $42.4M | 0.01% | +83,687+2.5% | Added |
| Victory Capital Management Inc | 3,520,231 | $44.4M | 0.05% | −1,044,699−22.9% | Reduced |
| RP Management, LLC | 3,846,154 | $48.5M | 22.39% | 00.0% | Unchanged |
| Pictet Asset Management SA | 4,813,772 | $60.7M | 0.09% | −1,233,189−20.4% | Reduced |
| Fisher Asset Management, LLC | 5,163,845 | $65.1M | 0.05% | −52,984−1.0% | Reduced |
| FMR LLC | 5,707,067 | $71.9M | 0.01% | +519,290+10.0% | Added |
| Avoro Capital Advisors LLC | 9,050,000 | $114.0M | 2.11% | +2,550,000+39.2% | Added |
| State Street Corp | 9,404,247 | $118.5M | 0.01% | −1,600,556−14.5% | Reduced |
| Baker Bros. Advisors LP | 12,710,818 | $160.2M | 1.05% | 00.0% | Unchanged |
| BlackRock Inc. | 13,774,995 | $173.6M | 0.01% | −212,423−1.5% | Reduced |
| Vanguard Group Inc | 13,838,612 | $174.4M | 0.01% | +28,439+0.2% | Added |
| Sofos Investments, Inc. | 26 | – | – | +4+18.2% | Added |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,101,611−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −644,100−100.0% | Sold out |
| HealthCor Management, L.P. | 0 | $0 | 0.00% | −239,820−100.0% | Sold out |
| Bain Capital Public Equity Management II, LLC | 0 | $0 | 0.00% | −224,763−100.0% | Sold out |
| Banque Pictet & Cie SA | 0 | $0 | 0.00% | −87,400−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −87,260−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −76,100−100.0% | Sold out |
| Park Avenue Securities LLC | 0 | $0 | 0.00% | −40,097−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −35,574−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −27,257−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −27,000−100.0% | Sold out |
| Kalos Management, Inc. | 0 | $0 | 0.00% | −23,900−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −15,988−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −14,081−100.0% | Sold out |
| New York Life Investments Alternatives | 0 | $0 | 0.00% | −13,219−100.0% | Sold out |
| InterOcean Capital Group, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −6,421−100.0% | Sold out |
| Fairfield, Bush & Co. | 0 | $0 | 0.00% | −2,065−100.0% | Sold out |
| CX Institutional | 0 | $0 | 0.00% | −1,760−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1,453−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,443−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −1,082−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Pinnacle Private Wealth, LLC | – | – | – | – | Not filed |
| Altium Wealth Management LLC | – | – | – | – | Not filed |
| Exane Derivatives | – | – | – | – | Not filed |